Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  COVID-19

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 401 articles:
HTML format



Single Articles


    December 2025

  1. Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2025;404:2543-2583.
    PubMed     Abstract available


    June 2025

  2. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.
    Lancet. 2025 Jun 24:S0140-6736(25)01037-2. doi: 10.1016/S0140-6736(25)01037.
    PubMed     Abstract available


  3. PAIL O, Lin MJ, Anagnostou T, Brown BD, et al
    Cancer vaccines and the future of immunotherapy.
    Lancet. 2025 Jun 17:S0140-6736(25)00553-7. doi: 10.1016/S0140-6736(25)00553.
    PubMed     Abstract available


    May 2025
  4. KAZATCHKINE M, Liden J
    Seeking an inclusive and just way to simplify the global health architecture.
    Lancet. 2025 May 29:S0140-6736(25)01100-6. doi: 10.1016/S0140-6736(25)01100.
    PubMed    


    April 2025
  5. AMOUZOU A, Barros AJD, Requejo J, Faye C, et al
    The 2025 report of the Lancet Countdown to 2030 for women's, children's, and adolescents' health: tracking progress on health and nutrition.
    Lancet. 2025 Apr 9:S0140-6736(25)00151-5. doi: 10.1016/S0140-6736(25)00151.
    PubMed    


  6. SUN L, Selbie D, Khan AS, Karim SSA, et al
    Mobilising national and regional assets and non-state actors for pandemic preparedness.
    Lancet. 2025 Apr 3:S0140-6736(25)00630-0. doi: 10.1016/S0140-6736(25)00630.
    PubMed    


  7. YUNAS I, Islam MA, Sindhu KN, Devall AJ, et al
    Causes of and risk factors for postpartum haemorrhage: a systematic review and meta-analysis.
    Lancet. 2025 Apr 3:S0140-6736(25)00448-9. doi: 10.1016/S0140-6736(25)00448.
    PubMed     Abstract available


    March 2025
  8. GOSTIN LO, Friedman EA, Dhai A, Zia-Zarifi S, et al
    COVID-19: border closures violate human rights - Authors' reply.
    Lancet. 2025;405:1054.
    PubMed    


  9. SILVA DS, Razum O
    COVID-19: border closures violate human rights.
    Lancet. 2025;405:1053-1054.
    PubMed    


  10. SINGH B, Lipunga GD, Thangavelu P, Dhar S, et al
    A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention study.
    Lancet. 2025 Mar 10:S0140-6736(25)00263-6. doi: 10.1016/S0140-6736(25)00263.
    PubMed     Abstract available


  11. WEISS DJ, Dzianach PA, Saddler A, Lubinda J, et al
    Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum and Plasmodium vivax malaria, 2000-22: a spatial and temporal modelling study.
    Lancet. 2025 Mar 5:S0140-6736(25)00038-8. doi: 10.1016/S0140-6736(25)00038.
    PubMed     Abstract available


    February 2025
  12. WONG WC, Lin V, Fang X, Kidd M, et al
    The Lancet Commission on Transforming Primary Health Care in the Post-COVID-19 Era.
    Lancet. 2025 Feb 10:S0140-6736(25)00198-9. doi: 10.1016/S0140-6736(25)00198.
    PubMed    


    January 2025
  13. MUMFORD L, Hogg R, Taylor A, Lanyon P, et al
    Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study.
    Lancet. 2025;405:314-328.
    PubMed     Abstract available


  14. KERR S, Robertson C, Sheikh A
    Undervaccination and severe COVID-19 outcomes - Authors' reply.
    Lancet. 2025;405:302.
    PubMed    


  15. MORRIS JA
    Undervaccination and severe COVID-19 outcomes.
    Lancet. 2025;405:301-302.
    PubMed    


  16. JOFFE AR
    Undervaccination and severe COVID-19 outcomes.
    Lancet. 2025;405:301.
    PubMed    


  17. DUNCAN CJA
    Antibody testing to predict SARS-CoV-2 risk in immunocompromised people.
    Lancet. 2025;405:276-278.
    PubMed    


  18. THORNTON J
    Every Story Matters: public voices in the COVID-19 Inquiry.
    Lancet. 2025 Jan 14:S0140-6736(25)00095-9. doi: 10.1016/S0140-6736(25)00095.
    PubMed    


    December 2024
  19. RUBIN DT, Allegretti JR, Panes J, Shipitofsky N, et al
    Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
    Lancet. 2024 Dec 17:S0140-6736(24)01927-5. doi: 10.1016/S0140-6736(24)01927.
    PubMed     Abstract available


  20. DZAU VJ, Laitner MH, Shambaugh EL
    Strategic imperatives for health in the USA: a roadmap for the incoming presidential administration.
    Lancet. 2024;404:2371-2379.
    PubMed     Abstract available



  21. The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;404:2314-2340.
    PubMed     Abstract available


    November 2024
  22. FERRANTE M, D'Haens G, Jairath V, Danese S, et al
    Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
    Lancet. 2024 Nov 21:S0140-6736(24)01762-8. doi: 10.1016/S0140-6736(24)01762.
    PubMed     Abstract available


  23. DWYER-LINDGREN L, Baumann MM, Li Z, Kelly YO, et al
    Ten Americas: a systematic analysis of life expectancy disparities in the USA.
    Lancet. 2024 Nov 19:S0140-6736(24)01495-8. doi: 10.1016/S0140-6736(24)01495.
    PubMed     Abstract available


  24. DWYER-LINDGREN L, Kendrick P, Baumann MM, Li Z, et al
    Disparities in wellbeing in the USA by race and ethnicity, age, sex, and location, 2008-21: an analysis using the Human Development Index.
    Lancet. 2024 Nov 6:S0140-6736(24)01757-4. doi: 10.1016/S0140-6736(24)01757.
    PubMed     Abstract available


  25. ALWAN NA, Al-Aly Z
    Learning from long COVID: conceptualising action to tackle infection-associated non-communicable diseases.
    Lancet. 2024 Nov 6:S0140-6736(24)02256-6. doi: 10.1016/S0140-6736(24)02256.
    PubMed    



  26. Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.
    Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925.
    PubMed     Abstract available


    October 2024
  27. PAYNE AB, Watts JA, Mitchell PK, Dascomb K, et al
    Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
    Lancet. 2024;404:1547-1559.
    PubMed     Abstract available


    September 2024
  28. ROMANELLO M, Costello A
    The Lancet Countdown on health and climate change: competing interests and optimism bias - Authors' reply.
    Lancet. 2024;404:1197-1198.
    PubMed    


  29. BRINK N, Chersich MF
    The Lancet Countdown on health and climate change: competing interests and optimism bias.
    Lancet. 2024;404:1196.
    PubMed    


  30. BUTLER CD, Combs Bowles D, Hanigan IC, Harmer A, et al
    The Lancet Countdown on health and climate change: competing interests and optimism bias.
    Lancet. 2024;404:1196-1197.
    PubMed    


  31. ROMANELLO M, Beggs PJ, Cai W, Gordon-Strachan G, et al
    The Lancet Countdown on health and climate change: representation matters - Authors' reply.
    Lancet. 2024;404:1195-1196.
    PubMed    


  32. STREET R, Wright CY
    The Lancet Countdown on health and climate change: representation matters.
    Lancet. 2024;404:1194.
    PubMed    


  33. HORTON R
    Offline: Xenotransplantation-a new era beckons.
    Lancet. 2024;404:1181.
    PubMed    


  34. ELNAKIB S, Aly S, Asi YM, Shawar YR, et al
    The humanitarian system: politics can not be avoided.
    Lancet. 2024;404:1105-1106.
    PubMed    


  35. ST LOUIS P, Makali SL, Paul E
    Health-care workers in fragile and conflict-ridden contexts.
    Lancet. 2024;404:1105.
    PubMed    


  36. RAUSEI S, Bertolini AG
    Cuban doctors cannot be the definitive solution for Italy.
    Lancet. 2024;404:1103.
    PubMed    


  37. YANG X, Zhang Z, Zhang Z
    Building safe health-care environments in China: urgent challenges.
    Lancet. 2024;404:1101-1102.
    PubMed    


  38. HWANG TJ, Trinh QD, Sokolov E
    Safe and equitable use of clinical decision support systems.
    Lancet. 2024;404:1100-1101.
    PubMed    


  39. HORTON R
    Offline: From Wanless to Darzi-don't miss this opportunity (again).
    Lancet. 2024;404:1088.
    PubMed    


  40. NACHEGA JB, Muyembe-Tamfum JJ, Ntoumi F, Mbala-Kingebeni P, et al
    A call for global solidarity and rapid action to control mpox.
    Lancet. 2024;404:1099-1100.
    PubMed    



  41. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
    Lancet. 2024 Sep 13:S0140-6736(24)01867-1. doi: 10.1016/S0140-6736(24)01867.
    PubMed     Abstract available


  42. IMANI-MUSIMWA P, Ververs M
    Mpox and breastmilk: for once, can we act in time?
    Lancet. 2024 Sep 13:S0140-6736(24)01881-6. doi: 10.1016/S0140-6736(24)01881.
    PubMed    


    August 2024
  43. MACNAUGHTON J, Zeiler K
    Reimagining illness through post-COVID-19 condition: the need for radically interdisciplinary health research.
    Lancet. 2024;404:840-841.
    PubMed    


  44. ZAROCOSTAS J
    Many challenges for WHO-AFRO regional director candidates.
    Lancet. 2024;404:736-737.
    PubMed    


  45. BRANDA F, Ceccarelli G, Ciccozzi M, Scarpa F, et al
    Strengthening community resilience: lessons from COVID-19 for mpox prevention.
    Lancet. 2024 Aug 22:S0140-6736(24)01752-5. doi: 10.1016/S0140-6736(24)01752.
    PubMed    


  46. DELLGREN JL, Persad G, Emanuel EJ
    International coverage of GLP-1 receptor agonists: a review and ethical analysis of discordant approaches.
    Lancet. 2024 Aug 16:S0140-6736(24)01356-4. doi: 10.1016/S0140-6736(24)01356.
    PubMed    


  47. SAMARASEKERA U
    Understanding pandemic risks: the WHO Pandemic Hub.
    Lancet. 2024;404:420-421.
    PubMed    


  48. SHAH SA, Robertson C, Sheikh A
    Waiting list models must account for departures before treatment - Authors' reply.
    Lancet. 2024;404:432-433.
    PubMed    


  49. WOOD RM
    Waiting list models must account for departures before treatment.
    Lancet. 2024;404:431-432.
    PubMed    


  50. O'NEILL D
    Continuing challenges to health equity in Ireland.
    Lancet. 2024;404:431.
    PubMed    


  51. BANATVALA JE, Muir P, Irving W, Meader E, et al
    The role of the clinical virologist in pandemic responses.
    Lancet. 2024;404:430.
    PubMed    


  52. GARAY J, Kateeb E, Zeballos D, Souza LE, et al
    Inequity in sustainable health today.
    Lancet. 2024;404:429-430.
    PubMed    


  53. GREEN A
    Evelyn Fox Keller.
    Lancet. 2024;404:426.
    PubMed    


    July 2024
  54. GREENHALGH T, Sivan M, Perlowski A, Nikolich JZ, et al
    Long COVID: a clinical update.
    Lancet. 2024 Jul 31:S0140-6736(24)01136-X. doi: 10.1016/S0140-6736(24)01136.
    PubMed     Abstract available


  55. TRIUNFOL M
    Charges brought in Brazilian COVID-19 malpractice case.
    Lancet. 2024;404:325-326.
    PubMed    


  56. BISSONNETTE R, Warren RB, Pinter A, Agner T, et al
    Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
    Lancet. 2024 Jul 18:S0140-6736(24)01027-4. doi: 10.1016/S0140-6736(24)01027.
    PubMed     Abstract available


  57. FRANZ C, Holzscheiter A, Kickbusch I
    Germany's role in global health at a critical juncture.
    Lancet. 2024;404:82-94.
    PubMed     Abstract available


    June 2024
  58. SAMARASEKERA U
    No parties meeting the challenge on health in the UK.
    Lancet. 2024;403:2769-2770.
    PubMed    


  59. DIEDRICH L
    Illness politics and social media mobilisation.
    Lancet. 2024;403:2776-2777.
    PubMed    


  60. THE LANCET
    UK elections: the need for a healthy change.
    Lancet. 2024;403:2755.
    PubMed    


  61. GARCIA PJ, Saavedra J, Espinoza-Pajuelo L, Garcia-Terron FA, et al
    Why Latin America needs a regional Centre for Disease Control and Prevention.
    Lancet. 2024;403:2763-2765.
    PubMed    


  62. HIRST JE, Witt A, Mullins E, Womersley K, et al
    Delivering the promise of improved health for women and girls in England.
    Lancet. 2024 Jun 27:S0140-6736(24)01347-3. doi: 10.1016/S0140-6736(24)01347.
    PubMed    


  63. HO A, Galgut O, Faustini S, Peters N, et al
    Implications of suboptimal measles immunity in UK health-care workers.
    Lancet. 2024 Jun 26:S0140-6736(24)01011-0. doi: 10.1016/S0140-6736(24)01011.
    PubMed    


  64. SCHRECKER T
    Canada's reckoning?
    Lancet. 2024;403:2688.
    PubMed    


  65. ZAROCOSTAS J
    Mental health in emergencies requires "a major rethink".
    Lancet. 2024;403:2582.
    PubMed    


  66. AHSAN S
    Israel border closure denying health care to Gazans.
    Lancet. 2024;403:2581.
    PubMed    


  67. SAMARASEKERA U
    African vaccine manufacturing scheme to boost production.
    Lancet. 2024;403:2579-2580.
    PubMed    


  68. KUNKLER I
    Improving future UK pandemic management structure.
    Lancet. 2024;403:2592.
    PubMed    


  69. YOON JH, Kwon IH, Park HW
    The South Korean health-care system in crisis.
    Lancet. 2024;403:2589.
    PubMed    


  70. THE LANCET
    Taking persistent physical symptoms seriously.
    Lancet. 2024;403:2565.
    PubMed    


  71. MCCALL C
    Security concerns threaten Papua New Guinea relief efforts.
    Lancet. 2024;403:2471.
    PubMed    


  72. KOMAMURA K, Iwase M
    Clinical outcomes of the AdaptResponse trial.
    Lancet. 2024;403:2484.
    PubMed    


  73. FILIPPATOS G, Gold MR, Mullens W, Kusano K, et al
    Clinical outcomes of the AdaptResponse trial - Authors' reply.
    Lancet. 2024;403:2484-2485.
    PubMed    


  74. HORTON R
    Offline: The system is not working.
    Lancet. 2024;403:2470.
    PubMed    


  75. MOHAPATRA PR
    Responding to India's data and transparency.
    Lancet. 2024;403:2482-2483.
    PubMed    


  76. ANIRVAN P
    Blowing in the wind-India's health data and transparency issues.
    Lancet. 2024;403:2483-2484.
    PubMed    


  77. KELLY P, Lemmens R, Weimar C, Walsh C, et al
    Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial.
    Lancet. 2024 Jun 7:S0140-6736(24)00968-1. doi: 10.1016/S0140-6736(24)00968.
    PubMed     Abstract available


  78. WATTS G
    Martin Raw.
    Lancet. 2024;403:2372.
    PubMed    


  79. SAMARASEKERA U
    Calls for a focus on health risks in EU election.
    Lancet. 2024;403:2364.
    PubMed    


  80. TORNINI VA, Fernandez RW, Goldman OV, Suarez J, et al
    DEI infrastructures required for the best science and medicine.
    Lancet. 2024;403:2375.
    PubMed    


  81. HORTON R
    Offline: UK election-two issues you won't hear about.
    Lancet. 2024;403:2362.
    PubMed    


    May 2024
  82. PATERLINI M
    Warnings over Italian health-care devolution.
    Lancet. 2024;403:2279.
    PubMed    


  83. THORNTON J
    Infected blood report release marks a day of shame for the UK.
    Lancet. 2024;403:2276-2277.
    PubMed    


  84. THE LANCET
    Cyberattacks on health care-a growing threat.
    Lancet. 2024;403:2263.
    PubMed    


  85. KIMBALL AB, Jemec GBE, Sayed CJ, Kirby JS, et al
    Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
    Lancet. 2024 May 22:S0140-6736(24)00101-6. doi: 10.1016/S0140-6736(24)00101.
    PubMed     Abstract available


  86. LAXMINARAYAN R, Impalli I, Rangarajan R, Cohn J, et al
    Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance.
    Lancet. 2024 May 20:S0140-6736(24)00878-X. doi: 10.1016/S0140-6736(24)00878.
    PubMed     Abstract available


  87. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    PubMed    



  88. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2204-2256.
    PubMed     Abstract available


  89. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    PubMed    


  90. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    PubMed    


  91. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    PubMed    


  92. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    PubMed    


  93. WATTS G
    Alasdair Macintosh Geddes.
    Lancet. 2024;403:1846.
    PubMed    


  94. AUJLA M
    Art, plunder, fragile fault lines.
    Lancet. 2024;403:1844-1845.
    PubMed    


  95. USHER AD
    Organisations vie for control over pandemic financing.
    Lancet. 2024;403:1839-1840.
    PubMed    


  96. GREENHALGH T, MacIntyre CR, Ungrin M, Wright JM, et al
    Airborne pathogens: controlling words won't control transmission.
    Lancet. 2024;403:1850-1851.
    PubMed    


  97. YANG YT
    Protecting humanitarian aid workers: an urgent call.
    Lancet. 2024;403:1847.
    PubMed    


  98. ABUZERR S, Zinser K
    Amplifying the voices of women in the Gaza Strip.
    Lancet. 2024;403:1848-1849.
    PubMed    


  99. KNUPPEL A, Boyd A, Macleod J, Chaturvedi N, et al
    The long COVID evidence gap in England.
    Lancet. 2024 May 6:S0140-6736(24)00744-X. doi: 10.1016/S0140-6736(24)00744.
    PubMed    


  100. KIVIMAKI M, Batty GD
    Work as a health risk.
    Lancet. 2024;403:1747-1748.
    PubMed    


    April 2024
  101. GREEN A
    Tobias Welte.
    Lancet. 2024;403:1626.
    PubMed    


  102. ADEPOJU P
    Moderna stalls on African vaccine manufacturing plans.
    Lancet. 2024;403:1617.
    PubMed    


  103. MARCHALIK D, Rehm D
    On not cutting corners.
    Lancet. 2024;403:1623.
    PubMed    


  104. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    PubMed    



  105. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a sys
    Lancet. 2024 Apr 15:S0140-6736(24)00757-8. doi: 10.1016/S0140-6736(24)00757.
    PubMed     Abstract available


  106. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    PubMed    


  107. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    PubMed    


  108. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    PubMed    


  109. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    PubMed    


  110. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    PubMed    


  111. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    PubMed    


  112. HASHIM Z, Nath A, Tripathy NK
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337-1338.
    PubMed    


  113. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
    Lancet. 2024;403:1336.
    PubMed    


  114. GU X, Huang L, Zhang H, Cao B, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
    Lancet. 2024;403:1336-1337.
    PubMed    



  115. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    PubMed     Abstract available


    March 2024
  116. KULKARNI PS, Potey AV, Bharati S, Kunhihitlu A, et al
    The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
    Lancet. 2024 Mar 28:S0140-6736(24)00249-6. doi: 10.1016/S0140-6736(24)00249.
    PubMed     Abstract available


  117. SZANYI J, Howe S, Blakely T
    The importance of reporting accurate estimates of long COVID prevalence.
    Lancet. 2024;403:1136-1137.
    PubMed    


  118. WENHAM C, Stout L
    A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies.
    Lancet. 2024 Mar 22:S0140-6736(24)00156-9. doi: 10.1016/S0140-6736(24)00156.
    PubMed     Abstract available


  119. SHAWE-TAYLOR M, Greenwood D, Hobbs A, Dowgier G, et al
    Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign.
    Lancet. 2024 Mar 11:S0140-6736(24)00316-7. doi: 10.1016/S0140-6736(24)00316.
    PubMed    



  120. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden
    Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476.
    PubMed     Abstract available


  121. PARHIZ H, Atochina-Vasserman EN, Weissman D
    mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Lancet. 2024 Mar 7:S0140-6736(23)02444-3. doi: 10.1016/S0140-6736(23)02444.
    PubMed     Abstract available


    February 2024
  122. DHAIRYAWAN R
    Candour, care, and COVID-19.
    Lancet. 2024;403:718.
    PubMed    


  123. VORA NM, Hassan L, Plowright RK, Horton R, et al
    The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention.
    Lancet. 2024;403:597-599.
    PubMed    


  124. WALLER BY, Joseph VA, Keyes KM
    Racial inequities in homicide rates and homicide methods among Black and White women aged 25-44 years in the USA, 1999-2020: a cross-sectional time series study.
    Lancet. 2024 Feb 8:S0140-6736(23)02279-1. doi: 10.1016/S0140-6736(23)02279.
    PubMed     Abstract available


    January 2024
  125. MCCLOSKEY B, Saito T, Shimada S, Ikenoue C, et al
    The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt.
    Lancet. 2024 Jan 17:S0140-6736(23)02635-1. doi: 10.1016/S0140-6736(23)02635.
    PubMed     Abstract available


  126. WANG L, Wang Q, Gao GF
    Interpreting COVID-19 data from China: a call for caution - Authors' reply.
    Lancet. 2024;403:144-145.
    PubMed    


  127. QU Z
    Interpreting COVID-19 data from China: a call for caution.
    Lancet. 2024;403:144.
    PubMed    


  128. GULLIFORD MC, Steves CJ
    Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality.
    Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
    PubMed    



  129. Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
    PubMed     Abstract available


  130. SHAH SA, Robertson C, Sheikh A
    Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study.
    Lancet. 2024 Jan 11:S0140-6736(23)02744-7. doi: 10.1016/S0140-6736(23)02744.
    PubMed    


    December 2023

  131. How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases.
    Lancet. 2023 Dec 20:S0140-6736(23)02758-7. doi: 10.1016/S0140-6736(23)02758.
    PubMed    


  132. GILES-VERNICK T, Cheah PY, Matta G, Lima NT, et al
    Louis Pasteur, COVID-19, and the social challenges of epidemics.
    Lancet. 2023;400:2166-2168.
    PubMed    


  133. CHARLIER P
    Death and end of life in France after COVID-19.
    Lancet. 2023;402:2290.
    PubMed    


  134. HORTON R
    Offline: Boris Johnson and COVID-19-more light than heat.
    Lancet. 2023;402:2277.
    PubMed    


    November 2023
  135. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    PubMed     Abstract available


  136. ZIAUDDEEN N, Pantelic M, O'Hara ME, Hastie C, et al
    Impact of long COVID-19 on work: a co-produced survey.
    Lancet. 2023;402 Suppl 1:S98.
    PubMed     Abstract available


  137. VAN YPEREN J, Campillo-Funollet E, Memon A, Allman P, et al
    The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities.
    Lancet. 2023;402 Suppl 1:S94.
    PubMed     Abstract available


  138. WRENN K, Blomquist PB, Inzoungou-Massanga C, Olufon O, et al
    Surge of lower respiratory tract group A streptococcal infections in England in winter 2022: epidemiology and clinical profile.
    Lancet. 2023;402 Suppl 1:S93.
    PubMed     Abstract available


  139. RAMASAWMY M, Khan N, Sunkersing D, Banerjee A, et al
    Understanding ethnic inequalities in the design and implementation of digital health interventions for cardiometabolic disease: a qualitative study.
    Lancet. 2023;402 Suppl 1:S78.
    PubMed     Abstract available



  140. Nowcasting waiting lists for elective procedures and surgery in England: a modelling study.
    Lancet. 2023;402 Suppl 1:S74.
    PubMed     Abstract available


  141. MURPHY MH, O'Kane SM, Carlin A, Lahart IM, et al
    A peer-led walking intervention for adolescent girls (the WISH study): a cluster-randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S72.
    PubMed     Abstract available


  142. MORENO-AGOSTINO D, Das-Munshi J, Ploubidis GB
    Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study.
    Lancet. 2023;402 Suppl 1:S71.
    PubMed     Abstract available


  143. MARTIN A, Jamieson S
    Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews.
    Lancet. 2023;402 Suppl 1:S68.
    PubMed     Abstract available


  144. KROMYDAS T, Demou E, Leyland AH, Katikireddi SV, et al
    Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data.
    Lancet. 2023;402 Suppl 1:S62.
    PubMed     Abstract available


  145. KHAN Y, Verhaeghe N, Devleesschauwer B, Cavillot L, et al
    Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review.
    Lancet. 2023;402 Suppl 1:S61.
    PubMed     Abstract available


  146. KALBUS A, Cornelsen L, Ballatore A, Cummins S, et al
    Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2023;402 Suppl 1:S60.
    PubMed     Abstract available


  147. HINDOCHA A, Brennan L, Brewster L, Lunn J, et al
    The wider health and wellbeing needs of those accessing paediatric care in England: engaging with the hidden voices of children and young people.
    Lancet. 2023;402 Suppl 1:S50.
    PubMed     Abstract available


  148. HAZIR SG, Ryan C, Moore A, Lewis C, et al
    The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study.
    Lancet. 2023;402 Suppl 1:S47.
    PubMed     Abstract available


  149. DU Z, Wang L, Bai Y, Pei Y, et al
    Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study.
    Lancet. 2023;402 Suppl 1:S39.
    PubMed     Abstract available


  150. DOBBIN J, Soares CA, Burns F, Miall N, et al
    Medical consequences of "contingency accommodation" for people seeking asylum: thematic analysis of a survey from professionals working in contingency accommodation.
    Lancet. 2023;402 Suppl 1:S38.
    PubMed     Abstract available


  151. ARNOTT J, Troya MI, Joyce M, Khashan A, et al
    Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study.
    Lancet. 2023;402 Suppl 1:S23.
    PubMed     Abstract available


  152. ACHARYA A, Darzi A, Judah G
    An SMS and animated video intervention to increase uptake of breast cancer screening: a randomised controlled trial.
    Lancet. 2023;402 Suppl 1:S17.
    PubMed     Abstract available


    October 2023
  153. WANG Q, Bowen A, Ho J, Zhang RM, et al
    SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster.
    Lancet. 2023 Oct 31:S0140-6736(23)02278-X. doi: 10.1016/S0140-6736(23)02278.
    PubMed    


  154. ABBASI K, Ali P, Barbour V, Benfield T, et al
    Time to treat the climate and nature crisis as one indivisible global health emergency.
    Lancet. 2023 Oct 25:S0140-6736(23)02289-4. doi: 10.1016/S0140-6736(23)02289.
    PubMed    


  155. FRANK J, Mustard C, Smith P, Siddiqi A, et al
    Work as a social determinant of health in high-income countries: past, present, and future.
    Lancet. 2023;402:1357-1367.
    PubMed     Abstract available


  156. DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
    Scientific advisory councils in the COVID-19 response.
    Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
    PubMed    


    September 2023
  157. HOCHMAYR C, Kiechl-Kohlendorfer U, Griesmaier E
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply.
    Lancet. 2023;402:1132.
    PubMed    


  158. MATUCHANSKY C
    Natural SARS-CoV-2 infection-induced immune protection against re-infection.
    Lancet. 2023;402:1131.
    PubMed    


  159. ZHOU YB, Xu ZG
    COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection.
    Lancet. 2023;402:1131-1132.
    PubMed    


  160. QU Z
    Cautionary notes on the COVID-19 re-infection study.
    Lancet. 2023;402:1130-1131.
    PubMed    


  161. FLACCO ME, Martellucci CA, Manzoli L
    Extra data to confirm waning protection of omicron (B.1.1.529) natural immunity.
    Lancet. 2023;402:1129.
    PubMed    


  162. YANG C, Lapp L, Tebbutt SJ
    Overcoming COVID-19 vaccine hesitancy hurdles.
    Lancet. 2023;402:1129-1130.
    PubMed    


  163. TSAGKARIS C, Papazoglou AS, Moysidis DV, Papadakos SP, et al
    Striving to afford free health care in Greece during COVID-19.
    Lancet. 2023;402:1128-1129.
    PubMed    


  164. PALUMBO L, Picchio CA, Smallwood C, Salvi C, et al
    Community COVID-19 response in WHO's European region.
    Lancet. 2023;402:1127.
    PubMed    


  165. UMAR TP
    Arcturus (XBB.1.16) COVID-19 subvariant emergence in Indonesia.
    Lancet. 2023;402:1127-1128.
    PubMed    


  166. JASSAT W, Reyes LF, Munblit D, Caoili J, et al
    Long COVID in low-income and middle-income countries: the hidden public health crisis.
    Lancet. 2023;402:1115-1117.
    PubMed    


  167. MASSUDA A, Dall'Alba R, Chioro A, Temporao JG, et al
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply.
    Lancet. 2023;402:1041-1042.
    PubMed    


  168. PARENTE RCM, Queiroga M
    Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges.
    Lancet. 2023;402:1040-1041.
    PubMed    


  169. ZHANG H
    COVID-19 and Chinese nurses' mental health.
    Lancet. 2023;402:1039-1040.
    PubMed    


  170. HEYMANS S, Lakdawala NK, Tschope C, Klingel K, et al
    Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches.
    Lancet. 2023;402:998-1011.
    PubMed     Abstract available


  171. DZAU V, Swaminathan S, Baker C, Bright RA, et al
    The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation.
    Lancet. 2023 Sep 5:S0140-6736(23)01775-0. doi: 10.1016/S0140-6736(23)01775.
    PubMed    


  172. PERCIVAL V, Thoms OT, Oppenheim B, Rowlands D, et al
    The Lancet Commission on peaceful societies through health equity and gender equality.
    Lancet. 2023 Sep 4:S0140-6736(23)01348-X. doi: 10.1016/S0140-6736(23)01348.
    PubMed    


    August 2023
  173. DAI L, Duan H, Liu X, Zhou H, et al
    Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
    Lancet. 2023;402:687-689.
    PubMed    


  174. KUNG S, Hills T, Kearns N, Beasley R, et al
    New Zealand's COVID-19 elimination strategy and mortality patterns.
    Lancet. 2023 Aug 24:S0140-6736(23)01368-5. doi: 10.1016/S0140-6736(23)01368.
    PubMed    


  175. IFTEKHAR N, Sivan M
    Venous insufficiency and acrocyanosis in long COVID: dysautonomia.
    Lancet. 2023;402:e9.
    PubMed    


  176. KNAUL FM, Arreola-Ornelas H, Touchton M, McDonald T, et al
    Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption.
    Lancet. 2023 Aug 7:S0140-6736(23)00777-8. doi: 10.1016/S0140-6736(23)00777.
    PubMed     Abstract available


    July 2023
  177. HSU NC, Hsu CH
    COVID-19 and commerce complicate minimum unit pricing effects on health.
    Lancet. 2023;402:368.
    PubMed    


  178. WYPER GM, Mackay DF, Fraser C, Lewsey J, et al
    COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply.
    Lancet. 2023;402:368-369.
    PubMed    



  179. Pandemics move faster than funders.
    Lancet. 2023;402:367.
    PubMed    


  180. ZHOU J, Zhang Y, Mo K, Newbert H, et al
    mRNA vaccines do not stop with COVID-19.
    Lancet. 2023 Jul 27:S0140-6736(23)01514-3. doi: 10.1016/S0140-6736(23)01514.
    PubMed    


  181. O'BRIEN KL, Lemango E
    The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery.
    Lancet. 2023 Jul 17:S0140-6736(23)01468-X. doi: 10.1016/S0140-6736(23)01468.
    PubMed    


  182. RIFE EC, Cron RQ
    Janus kinase inhibition in juvenile idiopathic arthritis.
    Lancet. 2023 Jul 6:S0140-6736(23)01134-0. doi: 10.1016/S0140-6736(23)01134.
    PubMed    


    June 2023

  183. The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019.
    Lancet. 2023 Jun 29:S0140-6736(23)00860-7. doi: 10.1016/S0140-6736(23)00860.
    PubMed     Abstract available


  184. WIJAYA R, Johnson M, Campbell N, Stuart B, et al
    Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing.
    Lancet. 2023 Jun 29:S0140-6736(23)01180-7. doi: 10.1016/S0140-6736(23)01180.
    PubMed    


  185. PELOSI A
    Disrespectful language about patients with long COVID.
    Lancet. 2023;401:2108.
    PubMed    


  186. PRIYA GIRI S, Dubey A
    Loneliness in the time of COVID-19: an alarming rise.
    Lancet. 2023;401:2107-2108.
    PubMed    


  187. BAILEY C, Sanderson T, Townsley H, Goldman J, et al
    Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
    Lancet. 2023 Jun 19:S0140-6736(23)00917-0. doi: 10.1016/S0140-6736(23)00917.
    PubMed    


  188. LEGIDO-QUIGLEY H, Clark H, Nishtar S, Horton R, et al
    Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission.
    Lancet. 2023;401:2021-2023.
    PubMed    


  189. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
    PubMed     Abstract available


  190. PLATZBECKER U, Della Porta MG, Santini V, Zeidan AM, et al
    Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
    Lancet. 2023 Jun 9:S0140-6736(23)00874-7. doi: 10.1016/S0140-6736(23)00874.
    PubMed     Abstract available


  191. THE LANCET EDITORS
    Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2023 Jun 9:S0140-6736(23)01175-3. doi: 10.1016/S0140-6736(23)01175.
    PubMed    


  192. WOLF J, Johnston RB, Ambelu A, Arnold BF, et al
    Burden of disease attributable to unsafe drinking water, sanitation, and hygiene in domestic settings: a global analysis for selected adverse health outcomes.
    Lancet. 2023 Jun 5:S0140-6736(23)00458-0. doi: 10.1016/S0140-6736(23)00458.
    PubMed     Abstract available


    May 2023
  193. JAFFE S
    US health experts divided on social media age restrictions.
    Lancet. 2023;401:1757.
    PubMed    



  194. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response.
    Lancet. 2023 May 26:S0140-6736(23)00964-9. doi: 10.1016/S0140-6736(23)00964.
    PubMed    


  195. FLAHAULT A, Calmy A, Costagliola D, Drapkina O, et al
    No time for complacency on COVID-19 in Europe.
    Lancet. 2023 May 22:S0140-6736(23)01012-7. doi: 10.1016/S0140-6736(23)01012.
    PubMed    


  196. ZAROCOSTAS J
    With the COVID-19 PHEIC over, what next?
    Lancet. 2023;401:1642-1643.
    PubMed    


  197. MFINANGA SG, Gatei W, Tinuga F, Mwengee WMP, et al
    Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution.
    Lancet. 2023;401:1649.
    PubMed    


  198. JAFFE S
    US Surgeon General: loneliness is a public health crisis.
    Lancet. 2023;401:1560.
    PubMed    


  199. EMANUEL EJ, Persad G
    The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19.
    Lancet. 2023 May 9:S0140-6736(23)00812-7. doi: 10.1016/S0140-6736(23)00812.
    PubMed     Abstract available


    April 2023
  200. AGRAWAL U, Robertson C, Sheikh A
    Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply.
    Lancet. 2023;401:1424.
    PubMed    


  201. BRANCH-ELLIMAN W, Monach PA
    Moving towards a precision approach for prevention of severe COVID-19.
    Lancet. 2023;401:1423-1424.
    PubMed    


  202. SZAPOCZNIK J, Faviero G, Dansua AS, Bausch DG, et al
    The importance of accountability in tackling future pandemics.
    Lancet. 2023;401:1423.
    PubMed    


  203. GALVAO J
    COVID-19: forgetting a pandemic that is not over.
    Lancet. 2023;401:1422-1423.
    PubMed    


  204. THE LANCET
    Moving past the COVID-19 emergency in the USA.
    Lancet. 2023;401:1399.
    PubMed    


  205. ROSS I, Bick S, Ayieko P, Dreibelbis R, et al
    Effectiveness of handwashing with soap for preventing acute respiratory infections in low-income and middle-income countries: a systematic review and meta-analysis.
    Lancet. 2023 Apr 27:S0140-6736(23)00021-1. doi: 10.1016/S0140-6736(23)00021.
    PubMed     Abstract available


  206. CUENI T
    Lessons learned from COVID-19 to stop future pandemics.
    Lancet. 2023;401:1340.
    PubMed    


  207. HORTON R
    Offline: The UK COVID-19 Inquiry-be patient, but don't wait.
    Lancet. 2023;401:1324.
    PubMed    


  208. LURIE N, Sharfstein JM
    State-to-state differences in US COVID-19 outcomes: searching for explanations.
    Lancet. 2023;401:1314-1315.
    PubMed    


  209. PETROV AN, Dorough DS, Tiwari S, Welford M, et al
    Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic.
    Lancet. 2023 Apr 18:S0140-6736(23)00684-0. doi: 10.1016/S0140-6736(23)00684.
    PubMed    


  210. HOCHMAYR C, Auckenthaler M, Fink FM, Kiechl-Kohlendorfer U, et al
    Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19?
    Lancet. 2023;401:e20.
    PubMed    


  211. GOH AXC, Chae SR, Chiew CJ, Tang N, et al
    Characteristics of the omicron XBB subvariant wave in Singapore.
    Lancet. 2023;401:1261-1262.
    PubMed    


  212. KING B, Zhang X, Harcha WG, Szepietowski JC, et al
    Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
    Lancet. 2023 Apr 13:S0140-6736(23)00222-2. doi: 10.1016/S0140-6736(23)00222.
    PubMed     Abstract available



  213. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2023 Apr 12:S0140-6736(23)00510-X. doi: 10.1016/S0140-6736(23)00510.
    PubMed     Abstract available


  214. PERNER A, Venkatesh B
    Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia?
    Lancet. 2023 Apr 12:S0140-6736(23)00587-1. doi: 10.1016/S0140-6736(23)00587.
    PubMed    


    March 2023
  215. THE EDITORS OF THE LANCET
    Retraction-Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1141.
    PubMed    


  216. SUN L, Jia H, Yang T
    Chinese medical personnel after the COVID-19 pandemic.
    Lancet. 2023;401:1000.
    PubMed    


  217. FRIEL S, Collin J, Daube M, Depoux A, et al
    Commercial determinants of health: future directions.
    Lancet. 2023 Mar 22:S0140-6736(23)00011-9. doi: 10.1016/S0140-6736(23)00011.
    PubMed     Abstract available


  218. GILMORE AB, Fabbri A, Baum F, Bertscher A, et al
    Defining and conceptualising the commercial determinants of health.
    Lancet. 2023 Mar 22:S0140-6736(23)00013-2. doi: 10.1016/S0140-6736(23)00013.
    PubMed     Abstract available


  219. BOLLYKY TJ, Castro E, Aravkin AY, Bhangdia K, et al
    Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.
    Lancet. 2023 Mar 22:S0140-6736(23)00461-0. doi: 10.1016/S0140-6736(23)00461.
    PubMed     Abstract available



  220. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis.
    Lancet. 2023;401:833-842.
    PubMed     Abstract available


  221. COHEN C, Pulliam J
    COVID-19 infection, reinfection, and the transition to endemicity.
    Lancet. 2023;401:798-800.
    PubMed    


  222. QU Z
    International cooperation to end the COVID-19 pandemic.
    Lancet. 2023;401:820.
    PubMed    


  223. THE LANCET
    Long COVID: 3 years in.
    Lancet. 2023;401:795.
    PubMed    


  224. CARPIANO RM, Callaghan T, DiResta R, Brewer NT, et al
    Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.
    Lancet. 2023 Mar 2:S0140-6736(23)00136-8. doi: 10.1016/S0140-6736(23)00136.
    PubMed    


    February 2023
  225. HUANG S, Gao Z, Wang S
    China's COVID-19 reopening measures-warriors and weapons.
    Lancet. 2023;401:643-644.
    PubMed    


  226. HAY SI, Murray CJL
    Conflicting COVID-19 excess mortality estimates - Authors' reply.
    Lancet. 2023;401:433-434.
    PubMed    


  227. BAGER P, Nielsen J, Bhatt S, Nielsen LB, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432-433.
    PubMed    


  228. DONZELLI A
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:432.
    PubMed    


  229. MOETI M, Makubalo L, Gueye AS, Balde T, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    PubMed    


  230. O'NEILL D
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431.
    PubMed    


  231. SCHOLEY J, Karlinsky A, Kobak D, Tallack C, et al
    Conflicting COVID-19 excess mortality estimates.
    Lancet. 2023;401:431-432.
    PubMed    


  232. PAN Y, Wang L, Feng Z, Xu H, et al
    Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis.
    Lancet. 2023 Feb 8:S0140-6736(23)00129-0. doi: 10.1016/S0140-6736(23)00129.
    PubMed     Abstract available


  233. PREISER W, Maponga T
    So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward.
    Lancet. 2023 Feb 8:S0140-6736(23)00268-4. doi: 10.1016/S0140-6736(23)00268.
    PubMed    


  234. TAN H, Liu J, Zeng F
    China needs a scientific long COVID recovery-support platform.
    Lancet. 2023;401:344-345.
    PubMed    


    January 2023
  235. MOHEBBI N, Ritter A, Wiegand A, Graf N, et al
    Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Lancet. 2023 Jan 25:S0140-6736(22)02606-X. doi: 10.1016/S0140-6736(22)02606.
    PubMed     Abstract available


  236. ELNAIEM A, Mohamed-Ahmed O, Zumla A, Mecaskey J, et al
    Global and regional governance of One Health and implications for global health security.
    Lancet. 2023 Jan 19:S0140-6736(22)01597-5. doi: 10.1016/S0140-6736(22)01597.
    PubMed     Abstract available


  237. TRAORE T, Shanks S, Haider N, Ahmed K, et al
    How prepared is the world? Identifying weaknesses in existing assessment frameworks for global health security through a One Health approach.
    Lancet. 2023 Jan 19:S0140-6736(22)01589-6. doi: 10.1016/S0140-6736(22)01589.
    PubMed     Abstract available


  238. MWATONDO A, Rahman-Shepherd A, Hollmann L, Chiossi S, et al
    A global analysis of One Health Networks and the proliferation of One Health collaborations.
    Lancet. 2023 Jan 19:S0140-6736(22)01596-3. doi: 10.1016/S0140-6736(22)01596.
    PubMed     Abstract available


  239. ELLINGTON S, Jatlaoui TC
    COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy.
    Lancet. 2023 Jan 17:S0140-6736(22)02613-7. doi: 10.1016/S0140-6736(22)02613.
    PubMed    


  240. VILLAR J, Soto Conti CP, Gunier RB, Ariff S, et al
    Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.
    Lancet. 2023 Jan 17:S0140-6736(22)02467-9. doi: 10.1016/S0140-6736(22)02467.
    PubMed     Abstract available


  241. THE LANCET
    The COVID-19 pandemic in 2023: far from over.
    Lancet. 2023;401:79.
    PubMed    


  242. BAKER MG, Durrheim D, Hsu LY, Wilson N, et al
    COVID-19 and other pandemics require a coherent response strategy.
    Lancet. 2023 Jan 13:S0140-6736(22)02489-8. doi: 10.1016/S0140-6736(22)02489.
    PubMed    


    December 2022
  243. TIBBLE H, Mueller T, Proud E, Hall E, et al
    Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland.
    Lancet. 2022 Dec 22:S0140-6736(22)02398-4. doi: 10.1016/S0140-6736(22)02398.
    PubMed    


  244. KIDD MR, Kelly PM
    PANORAMIC: important insights into molnupiravir use in COVID-19.
    Lancet. 2022 Dec 22:S0140-6736(22)02593-4. doi: 10.1016/S0140-6736(22)02593.
    PubMed    


  245. BUTLER CC, Hobbs FDR, Gbinigie OA, Rahman NM, et al
    Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
    Lancet. 2022 Dec 22:S0140-6736(22)02597-1. doi: 10.1016/S0140-6736(22)02597.
    PubMed     Abstract available


  246. SELVARAJAH S, Corona Maioli S, Deivanayagam TA, de Morais Sato P, et al
    Racism, xenophobia, and discrimination: mapping pathways to health outcomes.
    Lancet. 2022;400:2109-2124.
    PubMed     Abstract available


  247. DEVAKUMAR D, Selvarajah S, Abubakar I, Kim SS, et al
    Racism, xenophobia, discrimination, and the determination of health.
    Lancet. 2022;400:2097-2108.
    PubMed     Abstract available


  248. ELSON W, Zambon M, de Lusignan S
    Integrated respiratory surveillance after the COVID-19 pandemic.
    Lancet. 2022;400:1924-1925.
    PubMed    


    November 2022
  249. THE LANCET EDITORS
    Expression of concern: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2022 Nov 24:S0140-6736(22)02370-4. doi: 10.1016/S0140-6736(22)02370.
    PubMed    


  250. HORTON R
    Offline: COVID-19-the lessons that science forgot.
    Lancet. 2022;400:1753.
    PubMed    



  251. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022 Nov 18:S0140-6736(22)02185-7. doi: 10.1016/S0140-6736(22)02185.
    PubMed     Abstract available


  252. GOSTIN LO, Friedman EA, Hossain S, Mukherjee J, et al
    Human rights and the COVID-19 pandemic: a retrospective and prospective analysis.
    Lancet. 2022 Nov 17:S0140-6736(22)01278-8. doi: 10.1016/S0140-6736(22)01278.
    PubMed     Abstract available


  253. OWEN A, Diaz JV, Guyatt G, Lamontagne F, et al
    WHO Living Guidelines on antivirals for COVID-19 are evidence-based.
    Lancet. 2022 Nov 10. pii: S0140-6736(22)02306.
    PubMed    


  254. KALRA PR, Cleland JGF, Petrie MC, Thomson EA, et al
    Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02083.
    PubMed     Abstract available


  255. DOWRICK A, Rai T, Hinton L, Eacott B, et al
    Health inequalities, ethnic minorities and COVID19: interactive theatre workshop drawing on a qualitative interview study.
    Lancet. 2022;400 Suppl 1:S9.
    PubMed     Abstract available


  256. ZURIAGA A, Flannigan L, Wilson J, Weiss S, et al
    A partnership approach to supporting the health and wellbeing of the Charedi (Orthodox Jewish) community in London.
    Lancet. 2022;400 Suppl 1:S85.
    PubMed     Abstract available


  257. PANTELIC M, Ziauddeen N, Boyes M, O'Hara ME, et al
    The prevalence of stigma in a UK community survey of people with lived experience of long COVID.
    Lancet. 2022;400 Suppl 1:S84.
    PubMed     Abstract available


  258. TWEED S
    Experience of homelessness during the COVID-19 pandemic in Tower Hamlets, London: a health needs assessment.
    Lancet. 2022;400 Suppl 1:S82.
    PubMed     Abstract available


  259. TURNER G, de'Donato F, Kovats S, Hoeben A, et al
    Implementation of adaptation to climate change in public health in Europe: qualitative thematic analysis.
    Lancet. 2022;400 Suppl 1:S81.
    PubMed     Abstract available


  260. TORRESIN S, Ratcliffe E, Aletta F, Albatici R, et al
    The effect of indoor soundscape on sexual wellbeing during the COVID-19 lockdown in London: a thematic analysis of remote workers' experiences.
    Lancet. 2022;400 Suppl 1:S80.
    PubMed     Abstract available


  261. SCOTT S, McGowan VJ, Wildman JM, Bidmead E, et al
    COVID-19 and the role of Voluntary, Community, and Social Enterprises in northern England in responding to the needs of marginalised communities: a qualitative focus group study.
    Lancet. 2022;400 Suppl 1:S78.
    PubMed     Abstract available


  262. SERKA S, Mainwaring J
    Perspectives of education and mental health professionals on adolescent school-based mental health promotion: a qualitative exploration.
    Lancet. 2022;400 Suppl 1:S76.
    PubMed     Abstract available


  263. ROSENTHAL DM, Heys M, Schoenthaler A, Hayward A, et al
    How did living in temporary accommodation during the COVID-19 pandemic affect children younger than 5 years' access to health care and health outcomes? A qualitative study of key professionals in a socially and ethnically diverse and deprived area of
    Lancet. 2022;400 Suppl 1:S75.
    PubMed     Abstract available


  264. QI C, Osborne T, Bailey R, Hollinghurst J, et al
    Effect of the COVID-19 pandemic on incidence of long-term conditions in Welsh residents: a population linkage study.
    Lancet. 2022;400 Suppl 1:S69.
    PubMed     Abstract available


  265. NIRANJAN V, Fitzpatrick P, Morrogh R, O'Hagan K, et al
    Evaluation of community outreach feasibility programmes on improving cancer-related, preventive, health behaviour.
    Lancet. 2022;400 Suppl 1:S67.
    PubMed     Abstract available


  266. MCQUIRE C, Zuccolo L, Frennesson F, Butcher S, et al
    Prenatal alcohol prevention in the UK: mapping the landscape through systematic collaborative review.
    Lancet. 2022;400 Suppl 1:S64.
    PubMed     Abstract available


  267. MCKINLAY AR, Collins L, Fancourt D, Burton A, et al
    How did female survivors of abuse use the arts to support their mental health and wellbeing during the COVID-19 pandemic? A qualitative exploration of their views.
    Lancet. 2022;400 Suppl 1:S63.
    PubMed     Abstract available


  268. PARNHAM JC, Vamos EP, McKevitt S, Laverty AA, et al
    The UK's Free School Meals policy during the pandemic: a thematic content analysis of policy documents and debates.
    Lancet. 2022;400 Suppl 1:S62.
    PubMed     Abstract available


  269. TINNER L
    Exploring young people's perceptions of health and inequality through art: a co-produced qualitative study.
    Lancet. 2022;400 Suppl 1:S6.
    PubMed     Abstract available


  270. MAKANJUOLA A, Lynch M, Hartfiel N, Cuthbert A, et al
    Social return on investment of face-to-face versus online lifestyle coaching to improve mental wellbeing.
    Lancet. 2022;400 Suppl 1:S59.
    PubMed     Abstract available


  271. KEEBLE M, Adams J, Burgoine T
    Changes in online food access during the COVID-19 pandemic and associations with deprivation: a longitudinal analysis.
    Lancet. 2022;400 Suppl 1:S54.
    PubMed     Abstract available


  272. BURNS R, Campos-Matos I, Harron K, Aldridge RW, et al
    COVID-19 vaccination uptake for half a million non-EU migrants and refugees in England: a linked retrospective population-based cohort study.
    Lancet. 2022;400 Suppl 1:S5.
    PubMed     Abstract available


  273. GRAY BJ, Kyle RG, Challenger A, Davies AR, et al
    Mental health of the nursing and midwifery workforce in Wales during the COVID-19 pandemic: a cross-sectional analysis.
    Lancet. 2022;400 Suppl 1:S43.
    PubMed     Abstract available


  274. HUF SW, Woldmann L, Crespo RF, Grailey K, et al
    Implementing behavioural science informed letter interventions to increase COVID-19 vaccination uptake in uncontactable London residents: a difference-in-difference study in London, UK.
    Lancet. 2022;400 Suppl 1:S41.
    PubMed     Abstract available


  275. GEISMAR C, Nguyen V, Fragaszy E, Shrotri M, et al
    Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch).
    Lancet. 2022;400 Suppl 1:S40.
    PubMed     Abstract available


  276. DAWES J, May T, Fancourt D, Burton A, et al
    The impact of the COVID-19 pandemic on people experiencing homelessness: a qualitative interview study in the UK.
    Lancet. 2022;400 Suppl 1:S35.
    PubMed     Abstract available


  277. CURTIN EL, Widnall E, Dodd S, Limmer M, et al
    The Peer Education Project to improve mental health literacy in secondary school students in England: a qualitative realist evaluation.
    Lancet. 2022;400 Suppl 1:S34.
    PubMed     Abstract available


  278. BRIGHT D, Song J, Hillier S, Huws DW, et al
    Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study.
    Lancet. 2022;400 Suppl 1:S25.
    PubMed     Abstract available


  279. BEYNON C
    Exploring the association between obesity and problems with peer relationships in children: a nationally representative cross-sectional study.
    Lancet. 2022;400 Suppl 1:S21.
    PubMed     Abstract available


  280. BERNARD A, Salhi L, de Ossorno Garcia S, John A, et al
    Engagement of individuals aged 14-25 years with a digital mental health service during the COVID-19 pandemic in the UK: a cohort study of service usage data.
    Lancet. 2022;400 Suppl 1:S20.
    PubMed     Abstract available


  281. ANDREAE G, Scott S, Nguyen G, Bell Z, et al
    Food insecurity among pregnant women living in high-income countries: a systematic review.
    Lancet. 2022;400 Suppl 1:S17.
    PubMed     Abstract available


  282. GRIFFITHS ML, Gray BJ, Kyle RG, Davies AR, et al
    Shifting priorities and employment choices among workers in Wales during the COVID-19 pandemic: a longitudinal analysis.
    Lancet. 2022;400 Suppl 1:S1.
    PubMed     Abstract available


    October 2022

  283. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries.
    Lancet. 2022 Oct 31. pii: S0140-6736(22)01846.
    PubMed     Abstract available


  284. FRENK J, Chen LC, Chandran L, Groff EOH, et al
    Challenges and opportunities for educating health professionals after the COVID-19 pandemic.
    Lancet. 2022;400:1539-1556.
    PubMed     Abstract available


  285. DAS M, Keke K
    Pandemic solidarity across national borders saved lives.
    Lancet. 2022;400:1510-1511.
    PubMed    


  286. AGUS DB, Nguyen A, Sall AA, Bell J, et al
    COVID-19 and other adult vaccines can drive global disease prevention.
    Lancet. 2022 Oct 27. pii: S0140-6736(22)02084.
    PubMed    


  287. OPEL DJ, Brewer NT, Buttenheim AM, Callaghan T, et al
    The legacy of the COVID-19 pandemic for childhood vaccination in the USA.
    Lancet. 2022 Oct 26. pii: S0140-6736(22)01693.
    PubMed    


  288. LEFRANCOIS T, Malvy D, Atlani-Duault L, Benamouzig D, et al
    After 2 years of the COVID-19 pandemic, translating One Health into action is urgent.
    Lancet. 2022 Oct 21. pii: S0140-6736(22)01840.
    PubMed    


  289. AGRAWAL U, Bedston S, McCowan C, Oke J, et al
    Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales.
    Lancet. 2022;400:1305-1320.
    PubMed     Abstract available


  290. MSELLATI P, Sow K, Desclaux A, Cottrell G, et al
    Reconsidering the COVID-19 vaccine strategy in West and Central Africa.
    Lancet. 2022;400:1304.
    PubMed    


  291. IRVING SA, Sundaram ME
    Prioritisation of COVID-19 boosters in the omicron era.
    Lancet. 2022;400:1282-1283.
    PubMed    


  292. WONG CKH, Au ICH, Lau KTK, Lau EHY, et al
    Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kon
    Lancet. 2022;400:1213-1222.
    PubMed     Abstract available


  293. BURDET C, Ader F
    Real-world effectiveness of oral antivirals for COVID-19.
    Lancet. 2022;400:1175-1176.
    PubMed    


  294. FRENK J, Godal T, Gomez-Dantes O, Store JG, et al
    A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic.
    Lancet. 2022 Oct 7. pii: S0140-6736(22)01943.
    PubMed    


  295. WU MY, Carr EJ, Harvey R, Mears HV, et al
    WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.
    Lancet. 2022 Oct 6. pii: S0140-6736(22)01938.
    PubMed    


    September 2022
  296. HAMEED SS, Hall E, Grange Z, Sullivan C, et al
    Characterising adults in Scotland who are not vaccinated against COVID-19.
    Lancet. 2022;400:993-995.
    PubMed    


  297. THE LANCET
    COVID-19: the case for prosociality.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01761.
    PubMed    


  298. SACHS JD, Karim SSA, Aknin L, Allen J, et al
    The Lancet Commission on lessons for the future from the COVID-19 pandemic.
    Lancet. 2022 Sep 14. pii: S0140-6736(22)01585.
    PubMed    


  299. YEK C, Warner S, Mancera A, Kadri SS, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants.
    Lancet. 2022;400:809.
    PubMed    


  300. NYBERG T, Ferguson NM, Blake J, Hinsley W, et al
    Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply.
    Lancet. 2022;400:809-810.
    PubMed    


  301. ZHANG Y, Wang Y, Ning G, He P, et al
    Protecting older people: a high priority during the COVID-19 pandemic.
    Lancet. 2022;400:729-730.
    PubMed    


  302. THORNTON J
    New centre for pandemic therapeutics.
    Lancet. 2022;400:722.
    PubMed    


  303. GORMAN EA, O'Kane CM, McAuley DF
    Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management.
    Lancet. 2022 Sep 2. pii: S0140-6736(22)01439.
    PubMed     Abstract available


    August 2022
  304. UYEKI TM, Hui DS, Zambon M, Wentworth DE, et al
    Influenza.
    Lancet. 2022;400:693-706.
    PubMed     Abstract available


  305. BOLLYKY TJ, Angelino O, Wigley S, Dieleman JL, et al
    Trust made the difference for democracies in COVID-19.
    Lancet. 2022;400:657.
    PubMed    


  306. MOETI M, Gao GF, Herrman H
    Global pandemic perspectives: public health, mental health, and lessons for the future.
    Lancet. 2022;400:e3-e7.
    PubMed    



  307. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022;400:563-591.
    PubMed     Abstract available


  308. HILL M, Bandyopadhyay AS, Pollard AJ
    Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use.
    Lancet. 2022 Aug 18. pii: S0140-6736(22)01582.
    PubMed    


  309. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    PubMed     Abstract available


  310. SORENSEN RJD
    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    PubMed    


  311. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    PubMed    


  312. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    PubMed    


    July 2022

  313. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    PubMed     Abstract available


  314. THORNTON J
    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    PubMed    


  315. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    PubMed    


  316. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    PubMed    



  317. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    PubMed     Abstract available


  318. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    PubMed    


  319. DURRHEIM DN
    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    PubMed    


  320. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    PubMed    


  321. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    PubMed    


  322. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    PubMed    


  323. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    PubMed    


  324. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    PubMed    


    June 2022
  325. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    PubMed     Abstract available


  326. LADHANI SN
    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    PubMed    


  327. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    PubMed    


  328. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    PubMed    


  329. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    PubMed    


  330. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    PubMed     Abstract available


  331. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    PubMed     Abstract available


  332. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    PubMed    


  333. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    PubMed    


    May 2022
  334. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    PubMed    


  335. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    PubMed    


  336. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.
    PubMed    


  337. KICKBUSCH I, Liu A
    Global health diplomacy-reconstructing power and governance.
    Lancet. 2022 May 17. pii: S0140-6736(22)00583.
    PubMed     Abstract available


  338. YUAN S
    Zero COVID in China: what next?
    Lancet. 2022;399:1856-1857.
    PubMed    


  339. SHERLOCK PL
    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.
    PubMed    


  340. THE LANCET
    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.
    PubMed    


  341. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.
    PubMed    


  342. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.
    PubMed    


  343. ZHANG X, Zhang W, Chen S
    Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
    Lancet. 2022 May 6. pii: S0140-6736(22)00838.
    PubMed    


  344. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    PubMed     Abstract available


  345. DZAU VJ, Balatbat CA, Offodile AC 2nd
    Closing the global vaccine equity gap: equitably distributed manufacturing.
    Lancet. 2022 May 6. pii: S0140-6736(22)00793.
    PubMed    



  346. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    PubMed     Abstract available


    April 2022
  347. ADEPOJU P
    Africa CDC warns COVID-19 vaccine production could cease.
    Lancet. 2022;399:1683.
    PubMed    


  348. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
    Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
    Lancet. 2022;399:1741-1752.
    PubMed     Abstract available


  349. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
    PubMed    


  350. GRAMMATOPOULOS DK, Young L, Anderson NR
    Transforming the UK's diagnostics agenda after COVID-19.
    Lancet. 2022;399:1606.
    PubMed    


  351. JEFFORD M, Howell D, Li Q, Lisy K, et al
    Improved models of care for cancer survivors.
    Lancet. 2022;399:1551-1560.
    PubMed     Abstract available


  352. FISHER D, Suri S, Carson G
    What comes next in the COVID-19 pandemic?
    Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
    PubMed    


  353. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    PubMed    


  354. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    PubMed    


  355. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
    Host-targeting oral antiviral drugs to prevent pandemics.
    Lancet. 2022;399:1381-1382.
    PubMed    



  356. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    PubMed     Abstract available


  357. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    PubMed    


  358. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
    Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
    PubMed     Abstract available


  359. HAN X, Li J, Chen Y, Li Y, et al
    SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
    PubMed    


  360. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    PubMed     Abstract available


  361. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
    Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
    Lancet. 2022;399:1313-1321.
    PubMed     Abstract available


  362. ZAROCOSTAS J
    Mixed response to COVID-19 intellectual property waiver.
    Lancet. 2022;399:1292-1293.
    PubMed    


  363. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    PubMed    


  364. POST LA, Lorenzo-Redondo R
    Omicron: fewer adverse outcomes come with new dangers.
    Lancet. 2022;399:1280-1281.
    PubMed    


    March 2022
  365. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
    Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
    PubMed     Abstract available



  366. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    Lancet. 2022;399:1266-1278.
    PubMed     Abstract available


  367. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    PubMed    


  368. NIXON DF, Schwartz RE, Ndhlovu LC
    Booster vaccines for COVID-19 vaccine breakthrough cases?
    Lancet. 2022;399:1224.
    PubMed    


  369. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
    SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
    Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
    PubMed    


  370. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
    Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
    Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
    PubMed    


  371. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    PubMed    


  372. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    PubMed     Abstract available


  373. PREISER W, Fish T
    Sisonke: reaching several goals together.
    Lancet. 2022;399:1095-1097.
    PubMed    


  374. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
    Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
    PubMed     Abstract available


  375. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
    Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
    PubMed     Abstract available


  376. MILLS EJ, Reis G
    Evaluating COVID-19 vaccines in the real world.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
    PubMed    


  377. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
    Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Lancet. 2022;399:1070-1078.
    PubMed     Abstract available


  378. HAAGMANS BL, Koopmans MPG
    Spreading of SARS-CoV-2 from hamsters to humans.
    Lancet. 2022;399:1027-1028.
    PubMed    


  379. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
    Preparing for future pandemics in the Eastern Mediterranean region.
    Lancet. 2022;399:1032-1033.
    PubMed    


  380. ABUBAKAR I, Dalglish SL, Angell B, Sanuade O, et al
    The Lancet Nigeria Commission: investing in health and the future of the nation.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02488.
    PubMed    


  381. ANGELL B, Sanuade O, Adetifa IMO, Okeke IN, et al
    Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02722.
    PubMed     Abstract available



  382. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
    PubMed     Abstract available


  383. MANCA T, Baylis F, Munoz FM, Top KA, et al
    Prioritise research on vaccines for pregnant and breastfeeding women.
    Lancet. 2022;399:890-893.
    PubMed    


  384. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    PubMed    


  385. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
    Brazil's COVID-19 guidelines: political hijack of public health.
    Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
    PubMed    


  386. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
    Travel measures in the SARS-CoV-2 variant era need clear objectives.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
    PubMed    


  387. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    PubMed     Abstract available


  388. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    PubMed    


    February 2022
  389. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    PubMed    


  390. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    PubMed    


  391. THE LANCET
    Our commitment to help accelerate progress against cancer.
    Lancet. 2022;399:769.
    PubMed    



  392. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
    PubMed     Abstract available


  393. GU X, Cao B
    Understanding of COVID-19 from infection-fatality ratio.
    Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
    PubMed    


  394. BAJAJ SS, Maki L, Stanford FC
    Vaccine apartheid: global cooperation and equity.
    Lancet. 2022 Feb 23. pii: S0140-6736(22)00328.
    PubMed    


  395. ADAMS LV, Dorough DS
    Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
    Lancet. 2022;399:613-614.
    PubMed    


  396. BURKI T
    Fresh questions over Gates Foundation governance.
    Lancet. 2022;399:508.
    PubMed    


  397. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    PubMed    


  398. THE LANCET
    Managing the opioid crisis in North America and beyond.
    Lancet. 2022;399:495.
    PubMed    


  399. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    PubMed    


    January 2022
  400. WU M, Wall EC, Carr EJ, Harvey R, et al
    Three-dose vaccination elicits neutralising antibodies against omicron.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
    PubMed    


  401. LAXMINARAYAN R
    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO COVID-19 is free of charge.